SCHEMBL8979327

SCHEMBL8979327

CNN(C)c1cccc(SC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.41
RAB9A P51151 1/20 0.41
GRIN2D O15399 2/20 0.41
GRIN3B O60391 2/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2A Q12879 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
GRIN3A Q8TCU5 2/20 0.41
SCN1A P35498 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN3A Q9NY46 1/20 0.41
MAPT P10636 3/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TP53 P04637 2/20 0.38
POLB P06746 2/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4922030 0.79 ALDH1A1 (0.50) GAARAB9AGRIN2DGRIN3BGRIN1
SCHEMBL7262408 0.76 GRIN2D (0.47) GAARAB9AGRIN2DGRIN3BGRIN1
SCHEMBL22964348 0.74 SIGMAR1 (0.43) GAARAB9AGRIN2DGRIN3BGRIN1
SCHEMBL8979322 0.74 ACHE (0.46) RAB9AMAPTALDH1A1MEN1KMT2A
SCHEMBL12369342 0.73 GRIN2D (0.41) GAARAB9AGRIN2DGRIN3BGRIN1
SCHEMBL9033002 0.72 ALDH1A1 (0.34) RAB9AMAPTALDH1A1TP53SMN1; SMN2
SCHEMBL8979321 0.72 ACHE (0.41) RAB9AMAPTALDH1A1KMT2AHPGD
SCHEMBL8979210 0.72 HTR3E (0.50) GAARAB9AMAPTMEN1KMT2A
SCHEMBL28021366 0.72 ALDH1A1 (0.63) GAARAB9AALDH1A1HSD17B10CYP1A2
SCHEMBL3373713 0.72 MAPT (0.43) GAARAB9AGRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188097-B2 Pyrazolo[1,5-A]pyrimidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-05-29 US disclosed
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds TANABE SEIYAKU CO., LTD. (JP) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds RECQL, QTRT1, DPYD GAA 4136/4885RAB9A 364/4885GRIN2D 1622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.